During the past decade, Rochester Multiple Sclerosis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Multiple Sclerosis Center" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Multiple Sclerosis Center" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Rochester Multiple Sclerosis Center" in a lesser frequency.

Most popular intervention types in "Rochester Multiple Sclerosis Center" are "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "NAbs testing" (1 trials) and "alemtuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Multiple Sclerosis Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Multiple Sclerosis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rochester Multiple Sclerosis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Multiple Sclerosis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".